Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-23-000032
Filing Date
2023-01-11
Accepted
2023-01-10 20:04:25
Documents
5
Group Members
ALEXANDER J. DENNER, PH.D.LOUIS STERLING III

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #4 s58919650a.htm SC 13D/A 62809
2 EXHIBIT 4 - REQUISITION NOTICE, JANUARY 10, 2023 s58919650b.htm EX-99.1 8783
3 EXHIBIT 5 - PRESS RELEASE, JANUARY 10, 2023 s58919650c.htm EX-99.2 14480
4 EXHIBIT 6 - JOINT FILING AGREEMENT OF THE REPORTING PERSONS s58919650d.htm EX-99.3 3044
5 EXHIBIT 7 - POWER OF ATTORNEY s58919650e.htm EX-99.4 3637
  Complete submission text file 0000899140-23-000032.txt   94572
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Subject) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52399 | Film No.: 23522345
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

EIN.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A